Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

SS Innovations International (SSII) Long-Term Debt Repayments (2023 - 2025)

SS Innovations International recorded quarterly Long-Term Debt Repayments of -$3.1 million in Q4 2025, down 200.0% quarter-over-quarter from $3.1 million in Q3 2025.

SS Innovations International's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at -$3.1 million for Q4 2025.

  • In Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to -$3.1 million; the TTM figure through Dec 2025 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
  • Long-Term Debt Repayments came in at -$3.1 million for Q4 2025 at SS Innovations International, down from $3.1 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $4.2 million in Q1 2025 to a low of -$3.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 SS Innovations International 770.31 Mn 746.70 Mn 5.33 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -3.14 Mn
Dec 31, 2025 -3.14 Mn
Sep 30, 2025 3.14 Mn
Sep 30, 2025 3.14 Mn
Jun 30, 2025 -3.14 Mn
Jun 30, 2025 -3.14 Mn
Mar 31, 2025 4.21 Mn
Mar 31, 2025 4.21 Mn
Dec 31, 2023 36,660.00
Dec 31, 2023 36,660.00
Sep 30, 2023 -2.69 Mn
Sep 30, 2023 -2.69 Mn
Jun 30, 2023 2.76 Mn
Jun 30, 2023 2.76 Mn
Mar 31, 2023 12,360.00
Mar 31, 2023 12,360.00